Compound Summary
Compound Name: | propyl gallate |
Compound CID: | 4947 |
Synonyms: | propyl gallate 121-79-9 Propyl 3,4,5-trihydroxybenzoate N-Propyl gallate Tenox PG More... |
Iupac Name: | propyl 3,4,5-trihydroxybenzoate |
InChI: | InChI=1S/C10H12O5/c1-2-3-15-10(14)6-4-7(11)9(13)8(12)5-6/h4-5,11-13H,2-3H2,1H3 |
InChIKey: | ZTHYODDOHIVTJV-UHFFFAOYSA-N |
Canonical Smiles: | CCCOC(=O)C1=CC(=C(C(=C1)O)O)O |
Isomeric Smiles: | CCCOC(=O)C1=CC(=C(C(=C1)O)O)O |
Molecular Weight: | 212.2 |
Molecular Formula: | C10H12O5 |
Molecular Weight: | 212.2 |
Molecular Formula: | C10H12O5 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 15 |
Complexity: | 206 |
propyl gallate | propyl gallate |
---|---|
propyl gallate |
121-79-9 |
Propyl 3,4,5-trihydroxybenzoate |
N-Propyl gallate |
Tenox PG |
Progallin P |
Gallic acid, propyl ester |
Nipagallin P |
Gallic acid propyl ester |
NIPA 49 |
3,4,5-Trihydroxybenzoic acid propyl ester |
Benzoic acid, 3,4,5-trihydroxy-, propyl ester |
n-Propyl 3,4,5-trihydroxybenzoate |
3,4,5-Trihydroxybenzene-1-propylcarboxylate |
Propylester kyseliny gallove |
n-Propyl ester of 3,4,5-trihydroxybenzoic acid |
FEMA No. 2947 |
Gallic acid n-propyl ester |
NSC 2626 |
3,4,5-Trihydroxybenzoic acid, propyl ester |
NCI-C505888 |
3,4,5-Trihydroxybenzoic acid n-propyl ester |
UNII-8D4SNN7V92 |
Nipanox S 1 |
Propyl gallate (NF) |
Propyl gallate NF |
CHEMBL7983 |
Gallic acid, n-propyl ester |
E310 |
8D4SNN7V92 |
CHEBI:10607 |
NSC2626 |
NSC-2626 |
MFCD00002196 |
NCGC00164234-01 |
DSSTox_CID_1201 |
DSSTox_RID_76009 |
DSSTox_GSID_21201 |
Gallate, Propyl |
Pro gallin P |
CAS-121-79-9 |
CCRIS 541 |
HSDB 591 |
n-Propyl-3,4,5-Trihydroxybenzoate |
EINECS 204-498-2 |
Propylester kyseliny gallove Czech |
Propyl galiate |
AI3-17136 |
n-propyl-gallate |
Sustane PG |
n-Propyl gallate| |
Propylgallate,(S) |
Propyl Gallate FCC |
Propyl gallate, powder |
Propyl gallate, 98% |
ACMC-209ahq |
Gallic acid-propyl ester |
3,4,5-Trihydroxy-benzoic acid propyl ester |
Gallic acid propyl esterZ |
Oprea1_580415 |
SCHEMBL22630 |
CBDivE_013134 |
BIDD:ER0334 |
Propyl 3,5-trihydroxybenzoate |
WLN: QR BQ CQ EVO3 |
INS NO.310 |
DTXSID5021201 |
FEMA 2947 |
n-Propyl 3,5-trihydroxybenzoate |
Propyl gallate, >=98%, FCC |
INS-310 |
NCI-C50588 |
BCP13340 |
HY-N0524 |
ZINC1532172 |
Tox21_113531 |
Tox21_202286 |
Tox21_300060 |
BDBM50032154 |
CP0103 |
s5113 |
SBB060377 |
AKOS001603853 |
ANGC-121-79-9 |
5-Methyl-4,5-dihydrothiazole-2-thiol |
CCG-207932 |
DB12450 |
MCULE-2693876364 |
NCGC00164234-02 |
NCGC00164234-03 |
NCGC00164234-04 |
NCGC00254138-01 |
NCGC00259835-01 |
3,5-Trihydroxybenzene-1-propylcarboxylate |
3,5-Trihydroxybenzoic acid, propyl ester |
AC-11365 |
AC-34485 |
AS-11986 |
NCI60_002094 |
Propyl gallate, USP, 98.0-102.0% |
DB-003766 |
Benzoic acid,4,5-trihydroxy-, propyl ester |
CS-0009059 |
E-310 |
EU-0036319 |
FT-0626599 |
G0018 |
ST50307922 |
n-Propyl ester of 3,5-trihydroxybenzoic acid |
A19435 |
D02382 |
J10100 |
Propyl gallate, antioxidant, >=98.0% (HPLC) |
Q608726 |
SR-01000944710 |
Propyl gallate, for microscopy, >=98.0% (HPLC) |
Q-201634 |
SR-01000944710-1 |
EFFF5FFA-651C-4DE3-A25F-D807C65D5537 |
Propyl gallate, European Pharmacopoeia (EP) Reference Standard |
Propyl gallate, United States Pharmacopeia (USP) Reference Standard |
Propyl gallate, Pharmaceutical Secondary Standard; Certified Reference Material |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 53.000000000000000 | umol/L | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 50.000000000000000 | umol/L | 1.290000000000000 | Unclear | N2 | 33683565 | |||||||
Caenorhabditis elegans | 100.000000000000000 | umol/L | 5.050000000000000 | Unclear | N2 | 33683565 | |||||||
Caenorhabditis elegans | 500.000000000000000 | umol/L | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 1.300000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 1.000000000000000 | mM | Unclear | N2 | 33683565 | ||||||||
Bactrocera musae | 25.000000000000000 | ug/mL | 34.780000000000000 | 15.100000000000000 | 76.330000000000000 | Unclear | MALES | 8950031 | |||||
Bactrocera musae | 25.000000000000000 | ug/mL | 41.620000000000000 | 8.700000000000000 | 83.000000000000000 | Unclear | FEMALES | 8950031 | |||||
Caenorhabditis elegans | 1.000000000000000 | mM | 15.000000000000000 | 17.000000000000000 | 0.130000000000000 | S | N2 | 18755260 | Active | ||||
Caenorhabditis elegans | 1.000000000000000 | mM | 15.000000000000000 | 17.000000000000000 | 0.130000000000000 | S | N2 | 18755260 | Active | ||||
Caenorhabditis elegans | 200.000000000000000 | umol/L | 18.000000000000000 | 19.000000000000000 | 0.060000000000000 | S | N2 | 31820364 | Active | ||||
Caenorhabditis elegans | 100.000000000000000 | umol/L | 15.000000000000000 | 16.000000000000000 | 0.070000000000000 | NS | N2 | 18755260 | Inactive | ||||
Caenorhabditis elegans | 50.000000000000000 | umol/L | 15.000000000000000 | 17.000000000000000 | 0.130000000000000 | S | N2 | 18755260 | Active | ||||
Caenorhabditis elegans | 1.000000000000000 | mM | 15.000000000000000 | 16.000000000000000 | 0.070000000000000 | NS | N2 | 18755260 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Bactrocera musae | 15.100000000000000 | 1 | 2 | |
Caenorhabditis elegans | 0.130000000000000 | 5.050000000000000 | 3 | 12 |